MP-470 granted orphan drug designation

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2008年 / 8卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1373 / 1373
页数：1
相关论文
共 50 条
  • [1] Reports Isavuconazole Granted Orphan Drug Designation by US FDA
    不详
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (04) : II - II
  • [2] Effects of food on the single-dose pharmacokinetics of oral MP-470 capsules
    Kissling, J.
    Fine, G. D.
    Choy, G. S.
    Eddy, C.
    Berk, G. I.
    [J]. EJC SUPPLEMENTS, 2008, 6 (12): : 134 - 134
  • [3] IS ORPHAN DESIGNATION A DRIVER OF ORPHAN DRUG PRICING?
    Degrassat-Theas, A.
    Paubel, P.
    de Curzon, Parent O.
    Berard, F.
    Poisson, N.
    Le Pen, C.
    Sinegre, M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A302 - A302
  • [4] Orphan Drug Designation for Qutenza
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
  • [5] RegeneRx receives Orphan Drug designation
    不详
    [J]. WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2004, 16 (07): : A22 - +
  • [6] Worldwide collaboration for orphan drug designation
    Mariz, Segundo
    Reese, James H.
    Westermark, Kerstin
    Greene, Lesley
    Goto, Takahiro
    Hoshino, Tatsuro
    Llinares-Garcia, Jordi
    Sepodes, Bruno
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (06) : 440 - 440
  • [7] Worldwide collaboration for orphan drug designation
    Segundo Mariz
    James H. Reese
    Kerstin Westermark
    Lesley Greene
    Takahiro Goto
    Tatsuro Hoshino
    Jordi Llinares-Garcia
    Bruno Sepodes
    [J]. Nature Reviews Drug Discovery, 2016, 15 : 440 - 441
  • [8] Orphan Drug Designation and PharmacogenomicsOptions and Opportunities
    Paul D. Maher
    Marlene Haffner
    [J]. BioDrugs, 2006, 20 : 71 - 79
  • [9] Orphan drug designation for NTZ expanded
    不详
    [J]. AIDS PATIENT CARE AND STDS, 1997, 11 (03) : 198 - 198
  • [10] Yondelis granted orphan drug status by Swissmedic
    不详
    [J]. EJHP PRACTICE, 2008, 14 (03): : 14 - 14
12345